Sorafenib-triggered radiation recall dermatitis with a disseminated exanthematous reaction

Sorafenib is a multi-targeted kinase inhibitor, which is the current standard treatment for advanced hepatocellular carcinoma (HCC). Only one case of radiation recall dermatitis (RRD) associated with sorafenib has been reported so far. Our patient with recurrent HCC was treated with palliative radio...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Oh, Dongryul, Park, Hee Chul, Lim, Ho Yeong, Yoo, Byung Chul
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Society for Radiation Oncology 2013
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3797277/
https://ncbi.nlm.nih.gov/pubmed/24137563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3857/roj.2013.31.3.171
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak